| 07/02/2026 3:34 PM | Quest Diagnostics (1022079) Issuer WENTWORTH TIMOTHY C (1252016) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 3:32 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/04/2026 1:52 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/02/2026 5:38 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 11:26 AM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/21/2026 3:48 PM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/21/2026 3:52 PM | PFEIFFER GARY M (1127304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/08/2026 3:15 PM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/01/2026 3:15 PM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/30/2026 12:08 PM | Quest Diagnostics (1022079) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 04/29/2026 1:39 PM | Quest Diagnostics (1022079) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G | |
Get the Latest News and Ratings for DGX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Quest Diagnostics and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/28/2026 4:22 PM | Quest Diagnostics (1022079) Filer | Form 424B2 Transaction specifc information for a delayed shelf offering | |
| 04/27/2026 3:17 PM | Quest Diagnostics (1022079) Subject | Form FWP | |
| 04/27/2026 7:47 AM | Quest Diagnostics (1022079) Filer | Form 424B2 Transaction specifc information for a delayed shelf offering | |
| 04/24/2026 5:23 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:23 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:23 PM | Lassiter Wright III (1805909) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:23 PM | CARTER ROBERT B (1197607) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:24 PM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:24 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/24/2026 5:24 PM | Quest Diagnostics (1022079) Issuer SAMAD SAM (1694295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/22/2026 3:12 PM | Quest Diagnostics (1022079) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/21/2026 5:48 AM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/06/2026 3:32 PM | Quest Diagnostics (1022079) Filer | Form DEF 14A | |
| 04/06/2026 3:33 PM | Quest Diagnostics (1022079) Filer | Form DEFA14A | |
| 04/02/2026 4:16 PM | Quest Diagnostics (1022079) Issuer WENTWORTH TIMOTHY C (1252016) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 10:36 AM | Quest Diagnostics (1022079) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/11/2026 5:03 PM | Quest Diagnostics (1022079) Issuer WENTWORTH TIMOTHY C (1252016) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/11/2026 5:05 PM | Quest Diagnostics (1022079) Issuer WENTWORTH TIMOTHY C (1252016) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:44 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:44 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:44 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:44 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:45 PM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:45 PM | Quest Diagnostics (1022079) Issuer SAMAD SAM (1694295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:43 PM | Deppe Michael J (1771759) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:43 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/05/2026 10:53 AM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/05/2026 9:55 AM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/05/2026 9:43 AM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/04/2026 3:37 PM | Deppe Michael J (1771759) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
The REAL Reason Trump is Invading Iran (Ad) For a moment…
Forget about Trump’s ties to Israel.
Forget about reports of Iran’s nuclear program.
Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. Click here to find out what it is. |
| 03/04/2026 3:37 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:37 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:38 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:38 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:38 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:39 PM | Quest Diagnostics (1022079) Issuer SAMAD SAM (1694295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 3:39 PM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/03/2026 11:53 AM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/03/2026 11:12 AM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/03/2026 10:52 AM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/02/2026 1:21 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/20/2026 4:06 PM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:07 PM | CARTER ROBERT B (1197607) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:08 PM | Lassiter Wright III (1805909) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:09 PM | Deppe Michael J (1771759) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:10 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:10 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:11 PM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:11 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:12 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:12 PM | Quest Diagnostics (1022079) Issuer SAMAD SAM (1694295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/20/2026 4:13 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/19/2026 9:34 AM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/19/2026 9:19 AM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/19/2026 9:23 AM | Doherty Catherine T. (1520897) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/10/2026 11:46 AM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/10/2026 5:53 AM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/12/2026 3:37 PM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/28/2025 3:30 PM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/28/2025 3:30 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 3:24 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/25/2025 8:42 AM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/18/2025 10:02 AM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/07/2025 3:29 PM | Davis J. E. (1599837) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:11 PM | Quest Diagnostics (1022079) Issuer SAMAD SAM (1694295) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:09 PM | CARTER ROBERT B (1197607) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:09 PM | DELANEY MARK E (1955265) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:10 PM | Gregg Vicky B (1510304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:10 PM | PFEIFFER GARY M (1127304) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:11 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 5:11 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2025 1:10 PM | PFEIFFER GARY M (1127304) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/21/2025 5:50 AM | Quest Diagnostics (1022079) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/21/2025 5:31 AM | Quest Diagnostics (1022079) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 09/30/2025 3:36 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/26/2025 3:12 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/25/2025 3:39 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/24/2025 3:10 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/23/2025 3:14 PM | PREVOZNIK MICHAEL E (1222679) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/25/2025 3:27 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Your withdrawal order could cost you in taxes (Ad) If you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answer to a multi-variable problem. Withdrawal sequencing, sequence-of-returns risk, Roth conversion timing, and legacy goals can all shift your real number significantly.
Research from Vanguard suggests advisor best practices - covering allocation, rebalancing, tax management, and behavioral coaching - may add roughly 3% in net annual return potential. Morningstar's 2025 data shows the average investor return gap is 1.2% per year due to mistimed buying and selling.
Get matched with a fiduciary advisor in your area at no cost and with no obligation to hire. Answer three quick questions to find your advisor match today |
| 08/21/2025 3:34 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2025 11:10 AM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/15/2025 4:22 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/15/2025 4:25 PM | KUPPUSAMY KARTHIK (1955217) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/15/2025 4:29 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/08/2025 3:40 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/06/2025 12:54 PM | Plewman Patrick (1497368) Reporting Quest Diagnostics (1022079) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |